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Abstract A study is presented of the activity and temperature
dependence of the ATPase inhibitor protein (IF1) from bovine
heart mitochondria and of synthetic partial IF1 peptides. The
results show that the IF1-(42^58) peptide is the most potent
inhibitory domain of IF1. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
The F1F0 ATP synthase of coupling membranes catalyzes
ATP synthesis driven by the protonmotive force (PMF) gen-
erated by respiratory or photoredox systems [1]. In mitochon-
dria, wasteful ATP hydrolysis by the F1F0 complex is specif-
ically inhibited by the ATPase inhibitor protein, IF1 [2^4].
IF1 associates reversibly in a 1:1 stoichiometry with F1F0,
from which it is displaced by the PMF, thus IF1 has no sig-
ni¢cant e¡ect on ATP synthesis [2]. The vpH component of
PMF, in particular the matrix pH, on which side IF1 is asso-
ciated with the complex, is the critical factor for its binding
and inhibitory activity [2,5,6]. In our laboratory it has been
found that IF1 also inhibits passive proton conduction by the
F1F0 complex [6].
Bovine IF1 is a basic protein of 84 amino acids [7] and is
present in other eukaryotes [8,9]. The amino acid sequence is
well conserved in these proteins. Studies from various labo-
ratories have attempted to identify the functional domain(s)
of the IF1 protein. Harris et al. [10,11] ¢rst suggested that an
K-helical rod encompassing residues 22^79 in bovine heart IF1
protein represents the functional segment (Fig. 1). Stout et al.
[12] showed that the synthetic peptide with the sequence
Phe22^Lys46 in bovine IF1 inhibits the ATPase activity in
the soluble F1. Papa et al. [13] and van Raij et al. [14] found,
however, that this peptide has no signi¢cant e¡ect on the
ATPase activity of the F1F0 complex.
Studies with proteolytic fragments of IF1 [15] and genetic
deletions in the recombinant protein [14] indicated that the
last 10^20 residues of the C-terminus are not directly essential
for the inhibitory activity. The same seems to apply to the ¢rst
13 residues of the N-terminus [14]. van Raij et al. [14] con-
cluded from their studies with recombinant products of bo-
vine IF1 that the minimal inhibitory sequence consists of res-
idues 14^47. Papa et al. [13] have, on the other hand, shown
that the synthetic peptide with the Phe42^Lys58 sequence of
bovine IF1 is equally e¡ective, as the natural complete IF1, in
inhibiting the ATPase activity of both the F1F0 complex in
the membrane and of soluble F1. The 42^58 segment has at
positions 48, 49, 55 and 56 four histidines. Histidine chemical
modi¢cation [5,6], site directed mutagenesis of His49 [16] and
chemical substitution of His48, 49, 55, 56 or of Lys46, 47, 58
in the synthetic 42^58 peptide [13] have shown that these
residues are directly responsible for the activity and pH de-
pendence of IF1.
In this paper a study is presented on the activity and tem-
perature dependence of IF1 and synthetic IF1 segments. The
results clearly establish that the Phe42^Lys58 segment of IF1
is the most potent inhibitory domain of IF1.
2. Materials and methods
2.1. Materials
CM C-25 Sephadex, ATP, phosphoenolpyruvate (PEP), NADH,
pyruvate kinase, lactate dehydrogenase, were from Boehringer; chem-
icals for synthesis and sequence were obtained from Applied Biosys-
tem; thioanisol and ethanediol from Fluka; tert-butylether from Car-
lo Erba. All other chemical reagents were of analytical grade.
2.2. Preparations
Inside-out vesicles of the inner mitochondrial membrane were ob-
tained by exposure of isolated bovine heart mitochondria [17] to ultra-
sonic energy in the presence of 4 mM EDTA at pH 8.5 (ESMP) or in
the presence of 1 mM MgATP (MgATP-SMP) [18]. Sequential treat-
ment of ESMP with Sephadex chromatography produced particles
from which IF1 was removed (SMP) [19]. IF1 was isolated from
MgATP-SMP according to [20]. Recombinant IF1 was a generous
gift of Professor John Walker (Medical Research Council, Cambridge,
UK). The protein concentration was determined by the Lowry meth-
od [13].
2.3. Assays
The ATP hydrolase activity was measured with an ATP-regenerat-
ing system as in [14,21].
2.4. Synthesis of peptides
Synthetic peptides with conserved or mutated sequences of IF1 were
obtained by a standard solid-phase method with a fully automatic
peptide synthesizer (model 431A of Applied Biosystem) using the
Fmoc chemistry [22]. After synthesis the peptides were deprotected
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by incubating for 2 h at room temperature in 83% tri£uoroacetic acid,
4% thioanisol, 2% ethanediol and 6% crystalline phenol. After cleav-
age, the peptides were precipitated by 10 vol. of anhydrous tert-butyl-
ether, pelleted, washed four additional times with ether and lyophi-
lized. The purity of the synthetic peptides was checked by reverse-
phase high performance liquid chromatography on a Perkin Elmer C-
8/10 column with a linear gradient of acetonitrile in 0.1% aqueous
tri£uoroacetic acid. The sequence of the synthetic peptides was veri-
¢ed by amino acid analysis performed with a fully automatic peptide
sequencer (model 473A of Applied Biosystems). The repetitive yield of
sequence analysis was higher than 90%. The solubility in water of the
wild and mutant IF1-(42^58) peptide and of IF1-(22^46) peptide was
s 10 mg/ml. The protein concentration of solutions of IF1 and IF1
synthetic peptides, prepared on a w/v basis, was checked using the
Lowry method against a standard solution of bovine albumin [13].
3. Results
Fig. 2 shows the titrations of the inhibitory e¡ects of the
puri¢ed native IF1, recombinant IF1 and IF1 synthetic poly-
peptide segments on the ATPase activity of ‘inside-out’ sub-
mitochondrial particles from bovine heart deprived of the
endogenous IF1 (SMP), measured at 21 and 37‡C. It can be
observed that the inhibitory a⁄nity of the active peptides
increases greatly with temperature. At both temperatures the
natural and the recombinant IF1 proteins exhibited the same
inhibitory a⁄nity. The synthetic peptide with the Phe42^
Lys58 sequence of the bovine IF1 showed, both at 21 and
37‡C, an inhibitory a⁄nity three times higher than the natural
and the recombinant IF1. Replacement of the four histidines
at positions 48, 49, 55 and 56 or of the three lysines at posi-
tions 46, 47 and 58 in the IF1-(42^58) peptide practically
abolished its inhibitory activity at both temperatures. The
IF1-(Phe22^Lys46) peptide, which exhibits inhibitory activity
on the puri¢ed F1 sector [12], did not exert any signi¢cant
inhibitory activity on the ATPase activity of the native F1F0
complex in SMP (see also [13,14]). It should be noted that,
like the complete IF1, the IF1-(42^58) peptide caused perma-
nent, stable inhibition of the ATPase activity of SMP (Fig. 3).
The I50 values for natural and recombinant IF1, when mea-
sured in the present study at 37‡C, are exactly the same as
those obtained at the same temperature by van Raaij et al. for
the recombinant IF1 [14]. Thus, the I50 values for the synthetic
IF1 peptides we have synthesized can be directly compared
with those obtained for the IF1 segments used by these au-
thors (see Section 4).
Fig. 4 illustrates the temperature dependence of the inhib-
itory activities of natural and recombinant IF1 and of the
synthetic IF1-(42^58) peptide. The I50 values of IF1 and of
IF1-(42^58) peptide decreased as the temperature was in-
creased from 21 to 37‡C (Fig. 4). It can be noted that I50
values of the IF1-(42^58) peptide were, in the temperature
range examined, always lower than the I50 values of IF1.
The latter decreased, however, more steeply as the temper-
ature increased. These results thus show that the IF1-(42^58)
peptide has an inhibitory a⁄nity signi¢cantly higher and a
binding energy lower than the complete IF1.
4. Discussion
The I50 values for inhibition of the ATPase activity of the
F1F0 complex in inside-out vesicles of bovine heart inner mi-
Fig. 1. The amino acid sequence of the bovine heart IF1. The solid
box contains the IF1-(42^58) peptide, the dotted box the IF1-(14^
47) peptide [14].
Fig. 2. Titration at two temperatures of the inhibitory e¡ect of natural IF1, recombinant IF1 and synthetic, conserved and mutant, IF1 seg-
ments on ATP hydrolase activity in SMP. SMP (1 mg/ml) were incubated in a reaction mixture containing: 200 mM sucrose, 10 mM Tris/ace-
tate, 1 mM K-EDTA, 6 mM MgCl2, 1 mM MgATP, pH 6.7 in the presence of IF1 or IF1 partial peptides in the concentration range reported
in the ¢gure. The mixture was incubated at 21‡C (a) or 37‡C (b) for 10 min and then an aliquot of the suspension containing 50 Wg particle
protein was added to 1 ml of the ATPase assay mixture containing: 200 mM sucrose, 50 mM KCl, 5 mM MgCl2, 10 U lactate dehydrogenase,
20 mM Tris/HCl, 0.1 mM NADH, 1 mM PEP, 4 U pyruvate kinase and 1 mM rotenone, pH 8.0. The ATPase activity, started by the addition
of 1 mM MgATP, was followed by monitoring the oxidation of NADH at 340 nm at the temperature of 21‡C (a) or 37‡C (b). Submitochon-
drial particles deprived of IF1 were incubated in the presence of: (E) natural IF1 ; (R) recombinant IF1 ; (a) IF1-(42^58) synthetic peptide;
(O) IF1-(22^46) synthetic peptide; (b) [Ala48,49,55,56]-IF1-(42^58) synthetic peptide; (F) [Ala46,47,58]-IF1-(42^58) synthetic peptide.
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tochondrial membrane show that, compared to the complete
IF1 from the same source or produced by heterologous ex-
pression, the synthetic IF1-(42^58) peptide, with an I50 of 220
nM at 21‡C and 9 nM at 37‡C, is the most potent inhibitory
IF1 partial segment among all those so far tested in our [13]
and other laboratories [14,23]. The inhibitory a⁄nity of the
IF1-(42^58) peptide has, in fact, an inhibitory a⁄nity for the
ATPase activity of the F1F0 complex even higher than that of
the complete IF1. The inhibitory activity of the IF1-(42^58)
peptide is permanent, i.e. the peptide^F1F0 complex is as sta-
ble as that formed by the complete IF1 (Fig. 3), exhibits the
same pH dependence, with an optimum at a pH around 6.5
[13], and a marked temperature dependence as the complete
IF1. The marked enhancement with temperature of the inhib-
itory a⁄nity of IF1 for the ATP synthase, could play an
important role in promoting e¡ective inhibition of wasteful
ATP hydrolysis, which, under conditions of respiratory de¢-
ciency, might be quite relevant at body temperatures around
37‡C.
No equivalent data are available on the pH and temper-
ature dependence of the inhibition of the ATPase activity of
the F1F0 complex exerted by the partial IF1 peptides tested by
van Raaij et al. [14]. Of the various IF1 peptides used by these
authors, the IF1 (10^47) synthetic peptide was reported to be
the minimal e¡ective inhibitory peptide. With an I50 of 45 nM
at 37‡C and pH 6.5 it is, however, ¢ve-fold less active than the
IF1-(42^58) peptide. Furthermore, at di¡erence with the IF1-
(42^58) peptide which produced a stable inhibition, the inhi-
bition of the ATPase activity by the IF1-(10^47) peptide was
reported to decrease during the assay period, this indicating
that the peptide^F1F0 complex was unstable [14]. Van Raaij et
al. [14] have proposed that the four histidines in the 42^58
segment increase the stability of the IF1^F1F0 complex. A
truncated IF1 peptide, missing up to 24 residues from the
C-terminus, i.e. the IF1-(1^60) peptide containing the IF1-
(42^58) segment, exhibited practically the same inhibitory af-
¢nity and stability as the complete IF1 and the IF1-(42^58)
peptide [14]. It seems possible to conclude that the 42^58 seg-
ment represents the primary critical domain of IF1. The in-
ability of the IF1-(23^84) peptide [14,23] and the IF1-(44^84)
peptide [14] to inhibit the ATPase activity of the F1F0 com-
plex, could result from an occlusion of the active 42^58 seg-
ment by the C-terminal region in the absence of the N-termi-
nus. The IF1-(42^58) peptide contains the residues K46 and
K47 which are shared by the 10^47 peptide, the H49, which
has been found to be responsible for the pH dependence of
the inhibitory activity of IF1 [16], three additional histidines
and one more lysine, which are likely to increase the stability
of the inhibitor^F1F0 complex. The pH dependence of the
inhibitory activity of IF1 and the IF1-(42^58) peptide with
optimum around 6.5 [13], indicates that positive charges on
protonated histidine imidazole groups in addition to those of
the lysines are involved in the binding of IF1 to negatively
charged dicarboxylic residues in the F1F0 complex. The se-
quence K46K47H48 could speci¢cally interact with the last
three residues of the conserved DELSEED sequence [24] at
position L 394^400 in the C-terminal domain of the L subunit
at the bottom of the F1 spherical body facing the F0 sector in
the membrane [24,25].
Recently, Cabezon et al. [26] have proposed that protona-
tion of His49 induces the IF1 to acquire a dimeric active state
which inhibits the ATPase activity of dimeric F1F0 complexes
[27]. Deprotonation of His49 results, according to these au-
thors [26] in the formation of an inactive IF1 tetramer. If the
dimer^tetramer interconversion of IF1, observed for the iso-
lated IF1, also takes place in the interaction of IF1 with the
F1F0 complex in the membrane, this interconversion could
represent an additional consequence of the histidine protona-
tion in the IF1-(42^58) domain.
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Fig. 3. Inhibitory e¡ect of recombinant IF1 and IF1-(42^58) syn-
thetic peptide on the ATP hydrolase activity of SMP. SMP (1 mg/
ml) were incubated in the same reaction mixture reported in the
legend to Fig. 1 at 37‡C in the absence (a) or in the presence of
0.075 WM recombinant IF1 (b), or in the presence of 0.025 WM IF1-
(42^58) synthetic peptide (c). For other details see Section 2 and the
legend to Fig. 2.
Fig. 4. Temperature dependence of the inhibitory e¡ect of natural
IF1, recombinant IF1 and synthetic IF1 (42^58) peptide on the ATP
hydrolase activity of SMP. The I50 for the inhibition of the ATP
hydrolase activity of SMP were obtained by incubating the particles
with (E) natural IF1, (R) recombinant IF1 and (a) IF1-(42^58) syn-
thetic peptide in a range of concentrations between 0 and 2 WM for
10 min at the temperatures reported in the ¢gure. The ATPase ac-
tivity was then started and measured as reported in the legend to
Fig. 2. For other details, see the legend to Fig. 2 and Section 2.
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